Matthias Buchler
Overview
Explore the profile of Matthias Buchler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
1163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caillard S, Meyer N, Solis M, Bertrand D, Jaureguy M, Anglicheau D, et al.
Kidney Int
. 2024 Nov;
107(2):338-347.
PMID: 39490986
The MTOR inhibitors have demonstrated antiviral properties, and prior non-randomized studies have suggested they may have a suppressive effect on BKPyV replication. Here, in this randomized, multicenter, controlled trial (BKEVER...
2.
Truchot A, Raynaud M, Helantera I, Aubert O, Kamar N, Divard G, et al.
J Am Soc Nephrol
. 2024 Oct;
PMID: 39412887
Background: Prognostic models are becoming increasingly relevant in clinical trials as potential surrogate endpoints, and for patient management as clinical decision support tools. However, the impact of competing risks on...
3.
Maanaoui M, Lenain R, Foucher Y, Buron F, Blancho G, Antoine C, et al.
Lancet Diabetes Endocrinol
. 2024 Sep;
12(10):716-724.
PMID: 39250921
Background: Islet transplantation has been associated with better metabolic control and quality of life than insulin treatment alone, but direct evidence of its effect on hard clinical endpoints is scarce....
4.
Uro-Coste C, Lambert C, Audard V, Couzi L, Caillard S, Buchler M, et al.
Nephrol Dial Transplant
. 2024 May;
40(3):475-483.
PMID: 38794882
Background: Recurrence of focal segmental glomerulosclerosis (FSGS) is common after kidney transplantation and is classically associated with a significant decrease in graft survival. A major risk factor is a prior...
5.
Giral M, Grimbert P, Morin B, Bouvier N, Buchler M, Dantal J, et al.
Transpl Int
. 2024 May;
37:11571.
PMID: 38694490
Once-daily extended-release tacrolimus (LCPT) exhibits increased bioavailability versus immediate-release (IR-TAC) and prolonged release (PR-TAC) tacrolimus. Improvements in tremor were previously reported in a limited number of kidney transplant patients who...
6.
Von Tokarski F, Fillon A, Maisons V, Thoreau B, Bayer G, Gatault P, et al.
BMC Nephrol
. 2023 Sep;
24(1):278.
PMID: 37730583
Background: Thrombotic microangiopathies (TMAs) are rare but can be severe in kidney transplant. recipients (KTR). Methods: We analysed the epidemiology of adjudicated TMA in consecutive KTR during the. 2009-2021 period....
7.
Faucher Q, Chadet S, Humeau A, Sauvage F, Arnion H, Gatault P, et al.
Metabolomics
. 2023 Sep;
19(9):83.
PMID: 37704888
Introduction: Ischemia-reperfusion injury (IRI) induces several perturbations that alter immediate kidney graft function after transplantation and may affect long-term graft outcomes. Given the IRI-dependent metabolic disturbances previously reported, we hypothesized...
8.
Monchaud C, Woillard J, Crepin S, Tafzi N, Micallef L, Rerolle J, et al.
Transpl Int
. 2023 Aug;
36:11366.
PMID: 37588007
LCP-tacrolimus displays enhanced oral bioavailability compared to immediate-release (IR-) tacrolimus. The ENVARSWITCH study aimed to compare tacrolimus AUC in stable kidney (KTR) and liver transplant recipients (LTR) on IR-tacrolimus converted...
9.
Tchatat Wangueu L, de Freminville J, Gatault P, Buchler M, Longuet H, Bejan-Angoulvant T, et al.
J Nephrol
. 2023 Aug;
36(7):1931-1943.
PMID: 37548826
Introduction: Hypertension is a burden for most kidney transplant recipients. Whether respect of hypertension guidelines results in better outcomes is unknown. Methods: In this multicenter study, office blood pressure at...
10.
Kaczmarek M, Halimi J, de Freminville J, Gatault P, Gueguen J, Goin N, et al.
J Clin Med
. 2023 May;
12(10).
PMID: 37240634
Background: The risk of bleeding after percutaneous biopsy in kidney transplant recipients is usually low but may vary. A pre-procedure bleeding risk score in this population is lacking. Methods: We...